Cytotoxic capacity of IL-15-stimulated cytokine-induced killer cells against human acute myeloid leukemia and rhabdomyosarcoma in humanized preclinical mouse models

Allogeneic stem cell transplantation (allo-SCT) has become an important treatment modality for patients with high risk acute myeloid leukemia (AML) and is also under investigation for soft tissue sarcomas. The therapeutic success is still limited by minimal residual disease (MRD) status ultimately l...

Descripció completa

Dades bibliogràfiques

Autors principals:	Eva eRettinger, Vida eMeyer, Hermann eKreyenberg, Andreas eVolk, Selim eKuci, Andre eWillasch, Ewa eKoscielniak, Simone eFulda, Winfried eWels, Halvard eBoenig, Thomas eKlingebiel, Peter eBader
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2012-04-01
Col·lecció:	Frontiers in Oncology
Matèries:	Rhabdomyosarcoma preclinical CIK cells immunotherapy in leukemia NSG mice
Accés en línia:	http://journal.frontiersin.org/Journal/10.3389/fonc.2012.00032/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!